From: Lifestyle determinants as predictor of severity of metabolic associated fatty liver disease (MAFLD)
Mild steatosis (N = 28) | Moderate-severe steatosis (N = 49) | *P value | r(Spearman correlation)** | #P value | |
---|---|---|---|---|---|
Subjective sleep quality | N(%) | N(%) | 0.798 | 0.052 | 0.656 |
Very good | 14(50) | 23(46.9) | |||
Fairly good | 10(35.7) | 16(32.7) | |||
Fairly bad | 4(14.3) | 10(20.4) | |||
Sleep latency | N(%) | N(%) | 0.025 | 0.203 | 0.077 |
Very good | 12(42.9) | 18(36.7) | |||
Fairly good | 5(17.9) | 2(4.1) | |||
Fairly bad | 6(21.4) | 6(12.2) | |||
Very bad | 5(17.9) | 23(46.9) | |||
Sleep duration score | N(%) | N(%) | 0.607 | − .060- | 0.602 |
Very good | 9(32.1) | 16(32.7) | |||
Fairly good | 6(21.4) | 16(32.7) | |||
Fairly bad | 11(39.3) | 13(26.5) | |||
Very bad | 2(7.1) | 4(8.2) | |||
Habitual sleep efficiency | N(%) | N(%) | 0.072 | .300 | 0.008 |
Very good | 18(64.3) | 17(34.7) | |||
Fairly good | 8(28.6) | 21(42.9) | |||
Fairly bad | 2(7.1) | 9(18.4) | |||
Very bad | 0(0) | 2(4.1) | |||
Sleep disturbance | N(%) | N(%) | 0.006 | .338 | 0.003 |
Very good | 3(10.7) | 1(2) | |||
Fairly good | 21(75) | 26(53.1) | |||
Fairly bad | 4(14.3) | 22(44.9) | |||
Sleep medication use | N(%) | N(%) | 1 | 0.087 | 0.453 |
No | 28(100) | 48(98) | |||
Yes | 0(0) | 1(2) | |||
Daytime dysfunction | N(%) | N(%) | 0.013 | .363 | 0.001 |
Very good | 13(46.4) | 7(14.3) | |||
Fairly good | 7(25) | 12(24.5) | |||
Fairly bad | 6(21.4) | 20(40.8) | |||
Very bad | 2(7.1) | 10(20.4) |